Workflow
皖仪科技(688600) - 2024 Q1 - 季度财报
WANYI SCIENCEWANYI SCIENCE(SH:688600)2024-04-26 14:04

Financial Performance - The company's operating revenue for Q1 2024 was ¥114,906,354.26, representing a decrease of 14.77% compared to the same period last year[5] - The net profit attributable to shareholders was -¥33,616,386.19, a significant decline of 2,357.25% year-over-year[5] - Basic and diluted earnings per share were both -¥0.25, reflecting a decrease of 2,600.00% compared to the previous year[6] - Total operating revenue for Q1 2024 was ¥114,906,354.26, a decrease of 14.7% compared to ¥134,821,939.07 in Q1 2023[15] - Net profit for Q1 2024 was a loss of ¥33,616,386.19, compared to a profit of ¥1,489,261.89 in Q1 2023, representing a significant decline[16] - The total comprehensive income for Q1 2024 was a loss of ¥33,616,386.19, compared to a gain of ¥1,489,261.89 in Q1 2023[16] Research and Development - The total R&D investment amounted to ¥43,785,860.20, which is 38.11% of operating revenue, an increase of 14.25 percentage points year-over-year[6] - Research and development expenses rose to ¥43,785,860.20 in Q1 2024, an increase of 36.1% from ¥32,169,477.07 in Q1 2023[15] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,272,220,071.37, a decrease of 3.60% from the end of the previous year[6] - The equity attributable to shareholders decreased by 6.73% to ¥800,360,991.34 compared to the end of the previous year[6] - The company's total liabilities increased to ¥471,859,080.03 in Q1 2024, compared to ¥461,565,209.43 in Q1 2023[15] - The company's current assets totaled RMB 997,405,303.06, down from RMB 1,055,411,034.93, indicating a decrease of about 5.5%[13] - The company's fixed assets decreased to RMB 102,002,458.10 from RMB 104,497,305.81, a decline of about 2.4%[13] Cash Flow - The net cash flow from operating activities was -¥14,945,672.69, indicating a negative cash flow situation[5] - In Q1 2024, the company reported cash inflows from operating activities of CNY 159,209,139.62, an increase of 9.3% compared to CNY 145,420,329.60 in Q1 2023[17] - The net cash flow from operating activities was -CNY 14,945,672.69, an improvement from -CNY 17,008,118.16 in the same period last year[17] - Cash inflows from investment activities totaled CNY 206,912,853.38, up 35.8% from CNY 152,347,275.02 in Q1 2023[18] - The net cash flow from investment activities increased significantly to CNY 57,729,010.88, compared to CNY 27,907,079.13 in Q1 2023[18] - The net cash flow from financing activities was CNY 11,533,827.02, a turnaround from -CNY 331,590.71 in the previous year[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 3,616[10] - The total equity attributable to shareholders decreased to ¥800,360,991.34 in Q1 2024 from ¥858,149,839.47 in Q1 2023, a decline of 6.7%[15] Other Notable Points - The company reported non-recurring gains and losses totaling ¥5,344,460.53 for the period[8] - The company has not reported any significant new product developments or market expansions in the current quarter[12] - The company reported a significant increase in credit impairment losses, amounting to ¥2,539,353.35 in Q1 2024, compared to ¥643,699.70 in Q1 2023[16] - Cash and cash equivalents increased to RMB 107,912,195.78 from RMB 50,900,270.10, representing a significant increase of approximately 111.8%[12] - The ending cash and cash equivalents balance rose to CNY 104,036,896.49, compared to CNY 93,193,848.64 at the end of Q1 2023, reflecting a 11.5% increase[18]